RCM
TMO icon

Ravenstone Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Ravenstone Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.9M Buy
23,658
+954
+4% +$458K 4.85% 9
2026
Q1 		$11.2M Buy
22,704
+525
+2% +$285K 5.57% 6
2025
Q4 		$12.9M Buy
22,179
+550
+3% +$311K 5.86% 5
2025
Q3 		$10.5M Buy
21,629
+173
+0.8% +$80.5K 5.13% 9
2025
Q2 		$8.7M Buy
21,456
+2,417
+13% +$1.01M 4.57% 13
2025
Q1 		$9.47M Buy
19,039
+1,577
+9% +$854K 5.51% 6
2024
Q4 		$9.08M Buy
17,462
+323
+2% +$178K 5.22% 9
2024
Q3 		$10.6M Buy
17,139
+570
+3% +$337K 6.38% 5
2024
Q2 		$9.16M Sell
16,569
-15
-0.1% -$8.59K 6.11% 6
2024
Q1 		$9.64M Buy
16,584
+60
+0.4% +$33.7K 6.42% 5
2023
Q4 		$8.77M Buy
16,524
+175
+1% +$84.7K 6.35% 5
2023
Q3 		$8.28M Sell
16,349
-158
-1% -$84.2K 6.87% 5
2023
Q2 		$8.61M Sell
16,507
-140
-0.8% -$75.5K 6.76% 3
2023
Q1 		$9.59M Sell
16,647
-395
-2% -$223K 7.74% 3
2022
Q4 		$9.38M Sell
17,042
-40
-0.2% -$21.2K 7.69% 3
2022
Q3 		$8.66M Buy
17,082
+120
+0.7% +$67.2K 7.59% 3
2022
Q2 		$9.22M Sell
16,962
-10
-0.1% -$5.5K 7.46% 2
2022
Q1 		$10M Buy
16,972
+1,332
+9% +$765K 6.96% 5
2021
Q4 		$10.4M Buy
15,640
+475
+3% +$297K 6.54% 3
2021
Q3 		$8.66M Buy
15,165
+1,905
+14% +$1.05M 6.4% 4
2021
Q2 		$6.69M Buy
+13,260
New +$6.26M 6% 5

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Ravenstone Capital Management's TMO Position: Q2 2026 in Review

Ravenstone Capital Management increased its Thermo Fisher Scientific (TMO) stake by 4.2% in Q2 2026, buying an estimated $458K and bringing the position to 23,658 shares worth $11.9M. The position accounts for 4.85% of the portfolio, ranked #9.

Ravenstone Capital Management first reported a position in TMO in Q2 2021 and has held it in 21 quarters since. The position peaked at $12.9M in Q4 2025. 2,602 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Ravenstone Capital Management held 23,658 shares of Thermo Fisher Scientific worth $11.9M as of Q2 2026.
  • Ravenstone Capital Management bought 954 Thermo Fisher Scientific shares in Q2 2026, an estimated $458K.
  • Thermo Fisher Scientific made up 4.85% of Ravenstone Capital Management's portfolio in Q2 2026, its #9 holding.
  • Ravenstone Capital Management first reported a position in Thermo Fisher Scientific in Q2 2021 and has held it in 21 quarters since.
  • Ravenstone Capital Management's Thermo Fisher Scientific position peaked at $12.9M in Q4 2025.
  • 2,602 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Ravenstone Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.